"ｍRNA" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonModerna's mRNA flu vaccine backed by FDA advisers - Reuters
- Moderna's mRNA flu vaccine backed by FDA advisers Reuters
- FDA panel recommends Moderna’s mRNA flu shot for older adults NBC News
- Key FDA committee unanimously recommends its first vaccine since 2023 NPR
- Moderna’s mRNA flu vaccine gets thumbs up from federal vaccine panel CIDRAP
- FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy The Boston Globe
- MRNA Stock Clocks Best Week In Over 4 Years On FDA Advisory Committee Endorsement For Flu Vaccine Yahoo Finance
- mRNA-based influenza vaccine expands the B cell response breadth in humans Nature
- FDA panel strongly backs Moderna's mRNA flu vaccine FirstWord Pharma
- Moderna flu vaccine wins unanimous support from FDA panel BioPharma Dive
Programming the immunological properties of mRNA vaccines for cancer - Nature
Programming the immunological properties of mRNA vaccines for cancer Nature
FDA panel backs first-of-its-kind flu vaccine using mRNA technology - PBS
FDA panel backs first-of-its-kind flu vaccine using mRNA technology PBS
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology - The Guardian
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology The Guardian
FDA Panel Unanimously Backs Moderna’s Breakthrough mRNA Flu Vaccine Amid Political Turbulence - P...
FDA Panel Unanimously Backs Moderna’s Breakthrough mRNA Flu Vaccine Amid Political Turbulence Pharmacy Times
FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy - statnews.com
FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy statnews.com
FDA Committee Votes Unanimously to Recommend mRNA Flu Vaccine - Drug Topics
FDA Committee Votes Unanimously to Recommend mRNA Flu Vaccine Drug Topics
FDA Advisory Panel Votes 9-0 in Favor of Moderna's mRNA Flu Vaccine, Setting Stage for August Dec...
FDA Advisory Panel Votes 9-0 in Favor of Moderna's mRNA Flu Vaccine, Setting Stage for August Decision BioPharm International
FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010 - Phar...
FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010 Pharmaceutical Executive
FDA panel backs first-of-its-kind flu vaccine using mRNA technology - Inquirer.com
FDA panel backs first-of-its-kind flu vaccine using mRNA technology Inquirer.com
Quick takes: Moderna mRNA flu vaccine review, NIH award for genital herpes vaccine, malaria monoc...
mRNA Patent Wars Update: Delaware Court Allows Moderna and Pfizer/BioNTech to Assert Laches in GS...
MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing - Yahoo Finance
MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing Yahoo Finance
WashU Medicine study finds new mRNA flu vaccine could reduce hospitalizations, deaths - First Ale...
WashU Medicine study finds new mRNA flu vaccine could reduce hospitalizations, deaths First Alert 4
FDA committee unanimously recommends first mRNA flu vaccine - NPR
FDA committee unanimously recommends first mRNA flu vaccine NPR
FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1...
FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010 | PharmExec Pharmaceutical Executive
FDA panel recommends mRNA flu vaccine for older adults - The Hill
FDA panel recommends mRNA flu vaccine for older adults The Hill
A cancer vaccine made just for you. mRNA is back and it's fighting melanoma - NPR
A cancer vaccine made just for you. mRNA is back and it's fighting melanoma NPR
Moderna’s mRNA flu shot wins unanimous support at FDA adcomm in rebuke of former leadership - Bio...
Moderna’s mRNA flu shot wins unanimous support at FDA adcomm in rebuke of former leadership BioSpace
Latin America and the Caribbean LNP-mRNA Formulations - Market Analysis, Forecast, Size, Trends a...
Towards mRNA therapeutics 2.0 - Nature
FDA experts endorse Moderna's mRNA seasonal flu shot - pharmaphorum
FDA experts endorse Moderna's mRNA seasonal flu shot pharmaphorum
FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama - Ars Technica
FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama Ars Technica
FDA panel supports first mRNA-based flu vaccine - fox42kptm.com
FDA panel supports first mRNA-based flu vaccine fox42kptm.com
FDA Advisory Panel Convenes Today to Weigh Moderna's mRNA-Based Flu Vaccine - BioPharm International
FDA Advisory Panel Convenes Today to Weigh Moderna's mRNA-Based Flu Vaccine BioPharm International
MRNA Stock Jumps as FDA Briefing Docs Ease Flu Shot Approval Concerns - Yahoo Finance
MRNA Stock Jumps as FDA Briefing Docs Ease Flu Shot Approval Concerns Yahoo Finance
New mRNA vaccine shrinks neuroblastoma tumors in preclinical study - News-Medical
New mRNA vaccine shrinks neuroblastoma tumors in preclinical study News-Medical
Cancer vaccines based on mRNA advance, despite US cuts - Reuters
Cancer vaccines based on mRNA advance, despite US cuts Reuters
FDA vaccine panel set to review Moderna mRNA flu shot - The Hill
FDA vaccine panel set to review Moderna mRNA flu shot The Hill
mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell e...
mRNA vaccines engage unconventional pathways in CD8+ T cell priming - Nature
mRNA vaccines engage unconventional pathways in CD8+ T cell priming Nature
Adverse events following SARS-CoV-2 mRNA vaccination in norwegian adolescents - Nature
Adverse events following SARS-CoV-2 mRNA vaccination in norwegian adolescents Nature
FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr. - MedPage Today
FDA Panel Endorses New Flu Shot That Uses Tech Dissed by RFK Jr. MedPage Today
FDA Panel Recommends mRNA Flu Vaccine for Older Adults - Newsradio 600 KOGO
FDA Panel Recommends mRNA Flu Vaccine for Older Adults Newsradio 600 KOGO
Childhood mRNA Cancer Vaccine Reduces Tumors by 70% - Neuroscience News
Childhood mRNA Cancer Vaccine Reduces Tumors by 70% Neuroscience News
Chairman Johnson Questions CDC Awarding Pfizer $1.24 Billion for mRNA COVID-19 Vaccines After FDA...
Chairman Johnson Questions CDC Awarding Pfizer $1.24 Billion for mRNA COVID-19 Vaccines After FDA Officials Recommended Warning of Fatal Outcomes U.S. Senator Ron Johnson (.gov)
Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny - Yahoo
Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny Yahoo
Multivalent mRNA vaccine platform with compatible antigens conferred broad-spectrum protection ag...
mRNA vaccines follow unconventional immune path to destroy tumors - WashU Medicine
mRNA vaccines follow unconventional immune path to destroy tumors WashU Medicine
Moderna Extends Rally as FDA Advisory Panel Reviews Flu Vaccine Application (MRNA) - Yahoo Finance
Moderna Extends Rally as FDA Advisory Panel Reviews Flu Vaccine Application (MRNA) Yahoo Finance
The same mRNA tech behind COVID shots may soon fight the flu too - kaaltv.com
The same mRNA tech behind COVID shots may soon fight the flu too kaaltv.com
Expanding global access to mRNA vaccines - Nature
mRNASyner: An Integrative Framework for Full-Length mRNA Sequence Optimization via Multimodule Sy...
mRNASyner: An Integrative Framework for Full-Length mRNA Sequence Optimization via Multimodule Synergistic Design ACS Publications
Protein-Based COVID-19 Vaccine Demonstrates Superior Tolerability to mRNA Comparator - Vaccine Ad...
Protein-Based COVID-19 Vaccine Demonstrates Superior Tolerability to mRNA Comparator Vaccine Advisor
Doctor explains Moderna's candidate for first MRNA flu shot - WCVB
Doctor explains Moderna's candidate for first MRNA flu shot WCVB
New Research Challenges Understanding of mRNA Vaccines and Establishes Innovative Way to Make The...
MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing - Zacks Investment Research
MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing Zacks Investment Research
European regulators recommend approval of combined mRNA vaccine for flu and COVID - CIDRAP
European regulators recommend approval of combined mRNA vaccine for flu and COVID CIDRAP
VaxLab: integrated platform for rapid multistrategy mRNA vaccine design - Nature
VaxLab: integrated platform for rapid multistrategy mRNA vaccine design Nature
Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile o...
New Study Shows How mRNA Vaccines Could Transform Cancer Treatment - Forbes
New Study Shows How mRNA Vaccines Could Transform Cancer Treatment Forbes
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC - Nature
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC Nature
Phase 3 trial finds Moderna mRNA flu vaccine outperforms standard vaccine in older adults - CIDRAP
Phase 3 trial finds Moderna mRNA flu vaccine outperforms standard vaccine in older adults CIDRAP
FDA panel backs first-of-its-kind flu vaccine using mRNA technology - TelegraphHerald.com
FDA panel backs first-of-its-kind flu vaccine using mRNA technology TelegraphHerald.com
mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive datase...
mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive dataset Nature
FDA advisers back Moderna's flu vaccine for older adults, 9-0 - Stock Titan
FDA advisers back Moderna's flu vaccine for older adults, 9-0 Stock Titan
Polymer–mRNA complexes for monocyte-trafficked, lymph node-targeted cancer vaccination - Nature
Polymer–mRNA complexes for monocyte-trafficked, lymph node-targeted cancer vaccination Nature
Human DHX29 detects nonoptimal codon usage to regulate mRNA stability - Science | AAAS
Human DHX29 detects nonoptimal codon usage to regulate mRNA stability Science | AAAS
FDA panel backs first-of-its-kind flu vaccine using mRNA technology - Santa Fe New Mexican
FDA panel backs first-of-its-kind flu vaccine using mRNA technology Santa Fe New Mexican
USTAT: Unified Sequential Template Amplification and Transcription—a fully synthetic mRNA manufac...
Tuning the immune response to mRNA vaccines - Nature
NFID Statement on mRNA Technology - National Foundation for Infectious Diseases
NFID Statement on mRNA Technology National Foundation for Infectious Diseases
COVID Was Just the Start: What’s Next for mRNA? - Medscape
Next-generation mRNA vaccines eliciting robust protection against multidrug-resistant Enterobacte...
New mRNA Vaccine Strategy Eradicates Tumors by Reprogramming Immune Cells - University of Houston
New mRNA Vaccine Strategy Eradicates Tumors by Reprogramming Immune Cells University of Houston
Rational design of rigid mRNA folding architecture to enhance intracellular processing and protei...
Moderna’s mRNA flu vaccine more effective than standard shot in late-stage trial - NBC News
Moderna’s mRNA flu vaccine more effective than standard shot in late-stage trial NBC News
Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and...
Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion Science | AAAS
Anticancer vaccine could shrink neuroblastoma tumours by 70 per cent - Irish Medical Times
Anticancer vaccine could shrink neuroblastoma tumours by 70 per cent Irish Medical Times
Amino acid supplementation enhances in vivo efficacy of lipid nanoparticle–mediated mRNA delivery...
Amino acid supplementation enhances in vivo efficacy of lipid nanoparticle–mediated mRNA delivery in preclinical models Science | AAAS
Mechanisms linking cytoplasmic decay of translation-defective mRNA to transcriptional adaptation ...
Mechanisms linking cytoplasmic decay of translation-defective mRNA to transcriptional adaptation Science | AAAS
mRNA vaccine developed for sequential selective organ-to-cell targeting of glioma - Nature
mRNA vaccine developed for sequential selective organ-to-cell targeting of glioma Nature
Current and future uses of RNA, including mRNA vaccines - The World Economic Forum
Current and future uses of RNA, including mRNA vaccines The World Economic Forum
Breaking barriers in prostate cancer: the mRNA vaccine breakthrough and what comes next - Nature
Breaking barriers in prostate cancer: the mRNA vaccine breakthrough and what comes next Nature
Neonatal mice immune response to COVID-19 mRNA vaccine - National Institutes of Health (.gov)
Neonatal mice immune response to COVID-19 mRNA vaccine National Institutes of Health (.gov)
Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine - The New England Journal...
Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine The New England Journal of Medicine
Sanofi scraps plan to develop next-generation mRNA seasonal flu vaccine - CIDRAP
Sanofi scraps plan to develop next-generation mRNA seasonal flu vaccine CIDRAP
Why mRNA is important for U.S. national security - Hopkins Bloomberg Center
Why mRNA is important for U.S. national security Hopkins Bloomberg Center
Double-reverse: FDA now says it will review Moderna’s mRNA flu vaccine - CIDRAP
Double-reverse: FDA now says it will review Moderna’s mRNA flu vaccine CIDRAP
Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA s...
Purdue mRNA therapy delivery system proves to be shelf-stable, storable - Purdue University
Purdue mRNA therapy delivery system proves to be shelf-stable, storable Purdue University
ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy - UT MD Anderson
ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy UT MD Anderson
Association of mRNA COVID-19 vaccination with overall survival in patients receiving immune check...
FDA’s abrupt flip-flop on Moderna’s mRNA flu shot highlights growing risks to drug-makers of inve...
FDA’s abrupt flip-flop on Moderna’s mRNA flu shot highlights growing risks to drug-makers of investing in vaccines The Conversation
FDA reverses course, refuses to review Moderna’s application for new mRNA flu vaccine - CIDRAP
FDA reverses course, refuses to review Moderna’s application for new mRNA flu vaccine CIDRAP
Scientists Develop a Smarter mRNA Therapy That Knows Which Cells to Target - Mount Sinai
Scientists Develop a Smarter mRNA Therapy That Knows Which Cells to Target Mount Sinai
CJ-1: an optimized mRNA platform with enhanced protein expression and minimal immunogenicity for ...
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade Nature
U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says - PBS
U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says PBS
Stanford Medicine study shows why mRNA COVID-19 vaccine can cause myocarditis - Stanford Medicine
Stanford Medicine study shows why mRNA COVID-19 vaccine can cause myocarditis Stanford Medicine
Why you should keep getting mRNA vaccines - Scientific American
Why you should keep getting mRNA vaccines Scientific American
New report sounds alarm on health fallout from mRNA vaccine funding cuts - Yale School of Public ...
New report sounds alarm on health fallout from mRNA vaccine funding cuts Yale School of Public Health